Mortality risk prediction in scleroderma-related interstitial lung disease: the SADL model
J Morisset, E Vittinghoff, BM Elicker, X Hu, S Le, JH Ryu… - Chest, 2017 - Elsevier
Background Interstitial lung disease (ILD) is an important cause of morbidity and mortality in
patients with scleroderma (Scl). Risk prediction and prognostication in patients with Scl-ILD …
patients with scleroderma (Scl). Risk prediction and prognostication in patients with Scl-ILD …
Assessing mortality models in systemic sclerosis-related interstitial lung disease
RL Mango, EL Matteson, CS Crowson, JH Ryu… - Lung, 2018 - Springer
Purpose The gender, age, and lung physiology (GAP) model, interstitial lung diseases—
GAP (ILD-GAP) model, and the smoking history, age, and diffusion capacity of the lung …
GAP (ILD-GAP) model, and the smoking history, age, and diffusion capacity of the lung …
Predictors of mortality and progression in scleroderma-associated interstitial lung disease: a systematic review
BACKGROUND Interstitial lung disease (ILD) is the leading cause of morbidity and mortality
in patients with systemic sclerosis (SSc); however, prognostication of SSc-associated ILD …
in patients with systemic sclerosis (SSc); however, prognostication of SSc-associated ILD …
Predicting mortality in systemic sclerosis-associated interstitial lung disease using risk prediction models derived from idiopathic pulmonary fibrosis
CJ Ryerson, D O'Connor, JV Dunne, F Schooley… - Chest, 2015 - Elsevier
BACKGROUND Mortality risk prediction tools have been developed in idiopathic pulmonary
fibrosis, however, it is unknown whether these models accurately estimate mortality in …
fibrosis, however, it is unknown whether these models accurately estimate mortality in …
[HTML][HTML] Early radiographic progression of scleroderma: lung disease predicts long-term mortality
ER Volkmann, DP Tashkin, MD Roth, J Goldin… - Chest, 2022 - Elsevier
Background Radiographic end points commonly are included in therapeutic trials for
systemic sclerosis (SSc)-interstitial lung disease (ILD); however, the relationship between …
systemic sclerosis (SSc)-interstitial lung disease (ILD); however, the relationship between …
[HTML][HTML] Computed tomography predictors of mortality or disease progression in systemic sclerosis–interstitial lung disease: a systematic review
Objective Although interstitial lung disease (ILD) is a major cause of morbidity and mortality
in systemic sclerosis (SSc), its prognostication remains challenging. Given that CT …
in systemic sclerosis (SSc), its prognostication remains challenging. Given that CT …
Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis
V Hax, M Bredemeier, ALD Moro, TR Pavan… - Seminars in Arthritis and …, 2017 - Elsevier
Introduction Interstitial lung disease (ILD) is currently the primary cause of death in systemic
sclerosis (SSc). Thoracic high-resolution computed tomography (HRCT) is considered the …
sclerosis (SSc). Thoracic high-resolution computed tomography (HRCT) is considered the …
Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model
W Wu, S Jordan, MO Becker, R Dobrota… - Annals of the …, 2018 - ard.bmj.com
Objectives To identify the predictive clinical characteristics and establish a prediction model
for the progression of mild interstitial lung disease (ILD) in patients with systemic sclerosis …
for the progression of mild interstitial lung disease (ILD) in patients with systemic sclerosis …
Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts
ER Volkmann, DP Tashkin, M Sim, N Li… - Annals of the …, 2019 - ard.bmj.com
Objective To assess survival and identify predictors of survival in patients with systemic
sclerosis-interstitial lung disease (SSc-ILD) who participated in the Scleroderma Lung …
sclerosis-interstitial lung disease (SSc-ILD) who participated in the Scleroderma Lung …
Predicting survival across chronic interstitial lung disease: the ILD-GAP model
CJ Ryerson, E Vittinghoff, B Ley, JS Lee, JJ Mooney… - Chest, 2014 - Elsevier
Background Risk prediction is challenging in chronic interstitial lung disease (ILD) because
of heterogeneity in disease-specific and patient-specific variables. Our objective was to …
of heterogeneity in disease-specific and patient-specific variables. Our objective was to …